NCT02079077View on ClinicalTrials.gov

Inducing Immune Quiescence to Prevent HIV Infection in Women

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

January 1, 2018

Conditions
HIV
Interventions
DRUG

Acetylsalicylic Acid (ASA)

Acetylsalicylic Acid (ASA) 81 mg. oral daily for two months

DRUG

Hydroxychloroquine (HCQ)

Hydroxychloroquine (HCQ) 200 mg. oral, daily for two months.

Trial Locations (1)

Unknown

Kenyan Aids Control Project/University of Nairobi, Nairobi

All Listed Sponsors
collaborator

University of Nairobi

OTHER

lead

University of Manitoba

OTHER

NCT02079077 - Inducing Immune Quiescence to Prevent HIV Infection in Women | Biotech Hunter | Biotech Hunter